| 前收市價 | 25.65 |
| 開市 | 25.65 |
| 買盤 | 19.15 |
| 賣出價 | 21.00 |
| 拍板 | 135.00 |
| 到期日 | 2026-01-16 |
| 今日波幅 | 25.65 - 25.65 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 453 |
ZacksMerck's Keytruda Obtains its First FDA Approval for Mesothelioma
The FDA approves MRK's Keytruda for first-line treatment of malignant pleural mesothelioma. This marks Keytruda's first approval for the given indication.
ZacksInvestors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know
Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
ZacksStudy: Merck and Daiichi's Lung Cancer Treatment Shows Promise
MRK and Daiichi Sankyo's patritumab deruxtecan shows statistically significant progression-free survival improvement in previously treated EGFR-mutated NSCLC.
